In B-ALL, which accounts for 80% of ALL, two molecular subtypes, BCR-ABL+ and BCR-ABL-like subgroups, are associated with high relapse rates and inferior survival in both childhood and adult B-ALL [3, 4]. Here, ABL1 is linked to acute lymphoblastic leukemia.